Help For Irritable Bowel Syndrome (IBS) - Education, Support, & Self Help for Irritable Bowel Syndrome
Heather & Company View Cart
Shop for IBSIBS Message BoardsIBS News & ReviewsStore Finder
IBS Diet & Recipes
IBS Books
IBS Supplements
Yoga for IBS
Hypnosis for IBS
Tummy Teas
Get The IBS Diet Cheat Sheet
Get Trigger Foods, Safe Foods, Ten Commandments of Eating for IBS, More!

Enter First Name:

Enter Email:

We value your privacy

All Boards >> Irritable Bowel Syndrome Research Library


Reged: 12/09/02
Posts: 7677
Loc: Seattle, WA
Long-term cannabis use increases risk for IBS
      10/19/17 04:04 PM

Long-term cannabis use increases risk for IBS
October 18, 2017

ORLANDO — Cannabis use increased the risk for irritable bowel syndrome in the general population, according to a poster presented at the World Congress of Gastroenterology at ACG 2017. Additionally, the effects may be worse among men, Caucasians and Hispanics.

To determine the association between long-term cannabis use and the endogenous cannabinoid system, researchers analyzed 4,709,043 patients from the 2014 Nationwide Inpatient Survey. They found 0.03% had a primary admission for IBS and 1.32% for cannabis use disorder.

Cannabis use disorder was correlated with an increased risk for IBS (OR = 2.03; 95% CI, 1.53-2.71). The risk increased for men (OR = 3.48; 95% CI, 1.98-6.12) compared with women (OR = 1.48; 95% CI, 0.88-2.5) and among Caucasians (OR = 5.28; 95% CI, 1.77-15.76) and Hispanics (OR = 1.8; 95% CI, 1.02-3.18) compared with African-Americans (OR = 1.8; 95% CI, 0.65-5.03).

Following propensity matched analysis, the researchers found that cannabis use disorder was correlated with an 80% increased risk for IBS (OR = 1.82; 95% CI, 1.27-2.6).

Recently, reported that chronic use of cannabinoid derivatives was also correlated with increased cannabinoid hyperemesis syndrome, which is categorized by episodes of severe nausea and cyclical vomiting. Symptoms improved with cannabis cessation. – by Talitha Bennett

Reference: Adejumo A, et al. P1150. Presented at: World Congress of Gastroenterology at American College of Gastroenterology Annual Scientific Meeting; Oct. 13-18, 2017; Orlando, FL.

Disclosure: Adejumo reports no relevant financial disclosures.

Heather is the Administrator of the IBS Message Boards. She’s the author of Eating for IBS and The First Year: IBS, and the CEO of Heather's Tummy Care. Join her IBS Newsletter. Meet Heather on Facebook!

Post Extras Print Post   Remind Me!     Notify Moderator

Entire thread
Subject Posted by Posted on
* Pharmaceutical HeatherAdministrator 07/14/03 01:50 PM
. * Long-term cannabis use increases risk for IBS HeatherAdministrator   10/19/17 04:04 PM
. * FDA approves new drug for chronic constipation HeatherAdministrator   01/26/17 03:05 PM
. * Mixed Opioid Agent Adds to Growing List of Therapies for IBS-D HeatherAdministrator   01/27/16 02:48 PM
. * Low-dose naltreoxone for the treatment of irritable bowel syndrome HeatherAdministrator   01/26/16 01:20 PM
. * Amitiza benefited patients with chronic idiopathic constipation HeatherAdministrator   02/10/15 04:15 PM
. * Medical Marijuana for Digestive Disorders: High Time to Prescribe? HeatherAdministrator   09/17/14 02:08 PM
. * Antibiotics Early in Life May Boost Obesity Risk HeatherAdministrator   08/18/14 03:13 PM
. * Antidepressants, psychological therapies effectively treated IBS HeatherAdministrator   07/15/14 02:49 PM
. * Proton pump inhibitor (acid reflux drugs) may cause heart disease